Skip to main content
. Author manuscript; available in PMC: 2009 Apr 30.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2008 May 8;28(7):1379–1384. doi: 10.1161/ATVBAHA.108.167049

Table 3.

Adjusted HRs for adverse outcomes after adjustment for Clinical (model 1), Clinical + CRP (model 2), and Clinical + Echocardiographic variables (model 3).

OUTCOME Model 1* p value Model 2 p value Model 3 p value
All Cause Mortality
- Quartile I vs IV 2.1(1.3–3.3) 0.003 2.0(1.2–3.2) 0.004 1.9(1.0–3.5) 0.04
- Per SDin log telomere length 1.3(1.1–1.5) 0.005 1.2(1.1–1.4) 0.009 1.2(1.0–1.5) 0.12
HF Hospitalization
- Quartile I vs IV 2.1(1.1–3.8) 0.02 2.0(1.1–3.7) 0.03 2.6(1.1–6.0) 0.03
- Per SDin log telomere length 1.3(1.0–1.5) 0.04 1.2(1.0–1.5) 0.06 1.4(1.0–1.9) 0.03
CV Events (MI, Stroke, or CV Death)
- Quartile I vs IV 1.7(1.0–3.0) 0.07 1.7(0.9–2.9) 0.08 1.7(0.9–3.5) 0.12
- Per SDin log telomere length 1.1(0.9–1.4) 0.20 1.1(0.9–1.4) 0.22 1.1(0.9–1.4) 0.33
*

Adjusted for Age, Gender, Ethnicity, LDL Cholesterol, HDL Cholesterol, Systolic Blood Pressure, Diastolic Blood Pressure, BMI, Stroke, Smoking, Diabetes, CHF

Adjusted for all variables in Model 1 + Log CRP

Adjusted for all variables in Model 1 + LVEF, Diastolic Dysfunction